Loading...
Loading...
BHC| Name | Value |
|---|---|
| Revenues | 1,944.0M |
| Cost of Revenue | 582.0M |
| Gross Profit | 1,362.0M |
| Operating Expense | 1,164.0M |
| Operating I/L | 175.0M |
| Other Income/Expense | -311.0M |
| Interest Income | 6.0M |
| Pretax | -136.0M |
| Income Tax Expense | 73.0M |
| Net Income/Loss | -209.0M |
Bausch Health Companies Inc. develops, manufactures, and markets pharmaceutical, medical device, and over-the-counter products in the areas of eye health, gastroenterology, and dermatology. The company operates through segments including Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products, offering a range of vision care, surgical, ophthalmic pharmaceuticals, gastroenterology, dermatological, and medical aesthetic devices. Its products are sold in the United States, Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East, generating revenue from the sale of branded and generic pharmaceuticals, OTC products, and medical devices.
